Assenagon Asset Management S.A. Spero Therapeutics, Inc. Transaction History
Assenagon Asset Management S.A.
- $65.1 Billion
- Q3 2025
A detailed history of Assenagon Asset Management S.A. transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 36,993 shares of SPRO stock, worth $87,673. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,993Holding current value
$87,673% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding SPRO
# of Institutions
50Shares Held
10.5MCall Options Held
0Put Options Held
186K-
Vanguard Group Inc Valley Forge, PA1.95MShares$4.62 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.62MShares$3.83 Million0.86% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$3.21 Million14.54% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$2.11 Million0.17% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny832KShares$1.97 Million0.0% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $83.1M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...